Benitec Biopharma Inc. (BNTC) Two-Stage Excess Return Model - Discounting Cash Flows
Benitec Biopharma Inc.
BNTC (NASDAQ)

Estimated Value

USD

Market Price USD

* Values are not guaranteed, please do your own
research before making investment decisions.

Two-Stage Excess Return Model

Used to estimate the value of companies based on two stages of growth. An initial period of high growth, represented by [Sum of discounted excess returns in Growth Stage], followed by a period of stable growth, represented by [Discounted excess return in terminal stage]. Excess Return models are better suited to calculate the intrinsic value of a financial company than an enterprise valuation model (such as the Discounted Free Cash Flow Model).

Read more: GitHub Documentation

Interactive Assumptions

Results

Estimated Value -2.46 Mil. USD
Book value of equity invested 2.53 USD
Sum of discounted excess returns in Growth Stage -26.3 Thou. USD
Terminal stage EPS -61.6 Thou. USD
Terminal stage Book Value 5.66 Thou. USD
Terminal stage Equity Cost 346.9 USD
Discounted excess return in terminal stage -2.43 Mil. USD
Excess Returns in the Terminal Stage -3.27 Mil. USD
Terminal Cost of Equity (the discount rate) 6.13%
Terminal year's excess return -61.95 Thou. USD
Average historical Return on Equity -1,089%
Average historical Payout Ratio -46.93%
Payout Ratio in stable stage 100.4%
Yield of the U.S. 10 Year Treasury Bond 4.24%

Historical and Forecasted Data

In USD

Edit Chart Values 2025 2026 2027 2028 2029

amounts of USD except for #

2024 LTM 2025 2026 2027 2028 2029
Beginning Book Value 0.146 4.6 4.6 -54.3 466.1 -2505 5426
Ending Book Value 4.6 2.53 -54.3 466.1 -2505 5426 5656
EPS -2.68 -1.63 -50.14 591.3 -5075 27280 -59096
Return on Equity -10,770% -56.07% -1,089% -1,089% -1,089% -1,089% -1,089%
Dividend per Share
0.765 8.76 70.93 -2104 19348 -59326
Payout Ratio -17.47% -46.93% -17.47% 12% 41.46% 70.92% 100.4%
Retained Earnings
-2.4 -58.9 520.4 -2971 7931 230.1
Equity Cost 0.009 0.282 0.282 -3.33 28.58 -153.6 332.8
Cost of Equity 6.13% 6.13% 6.13% 6.13% 6.13% 6.13% 6.13%
Excess Return -2.69 -1.91 -50.42 594.6 -5104 27433 -59429
Discounted Excess Return
-47.51 527.9 -4269 21622 -44133

amounts of USD except for #

Average LTM 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Net Income -13.26 -26.49 -21.75 -19.56 -18.56 -13.78 -8.3 2.87 -8.55 -4.37 -18.5 -8.83
Total Stockholders Equity 23.4 97.57 47.25 0.202 2.88 20.01 10.24 16.57 13.77 16.53 14.07 18.31
Return on Equity -1,090% -56.07% -10,770% -678.8% -92.76% -134.6% -50.1% 20.82% -51.74% -31.08% -101% -39.27%
Dividends Paid to Common Shareholders 29.53 29.53
Payout Ratio -20.15% -46.93% -17.47% -17.47% -17.47% -17.47% -17.47% -17.47% -17.47% -17.47% -17.47% -17.47%
Shares Outstanding 4.92 38.6 10.26 1.39 1.92 1.01 0.24 0.202 0.165 0.138 0.112 0.091
Earnings per Share -72.67 -1.63 -2.68 -14.12 -19.31 -27.27 -69.1 28.44 -103.6 -63.56 -331.6 -194.9
Dividend per Share 0.765 0.765
Dividend Growth Rate
Book Value 62.28 2.53 4.6 0.146 1.5 19.8 42.61 82.2 83.42 120.1 126.0 202.2
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us